Up Over 50%: Is Canopy Growth (TSX:WEED) a Buy at These Levels?

Given its growing addressable market, expanding market share, and improving margin, I expect Canopy Growth to deliver higher returns this year.

| More on:

There has been a lot of optimism in the cannabis sector over the past couple of months. Joe Biden’s victory and the legalization of recreational cannabis by four U.S. states have improved investors’ confidence. On Tuesday, democratic candidates won the two seats in Georgia, thus shifting the Senate’s control to Democrats, which could help in the cannabis decriminalization process.

So, amid the renewed interest in the cannabis sector, Canopy Growth’s (TSX:WEED)(NYSE:CGC) stock has increased by over 54% since the beginning of November. Despite the surge, the company still trades around 40% lower from its 2019 highs. Should you be buying Canopy Growth at these levels? Let’s first look at the growth prospects of the cannabis sector.

Cannabis sector’s outlook

In the United States, 36 states have legalized cannabis for medical purposes, while 15 states have legalized cannabis for recreational usage. Meanwhile, the federal government prohibits cannabis usage, which has been a significant hurdle for its growth prospects. Meanwhile, with democrats taking control of both House and Senate, pro-cannabis initiatives, such as the SAFE Banking Act and the MORE act could easily be cleared, allowing cannabis companies better access to the capital in the coming months.

Moreover, amid the increased expenses due to COVID-19, many state budgets have incurred significant deficits, which could prompt other state governments to legalize cannabis to earn additional tax revenue. So, the United States market offers enormous growth prospects. New Frontier Data expects legal cannabis in the United States to grow at a compound annual growth rate (CAGR) of 21% to reach US$41 billion by 2025.

Meanwhile, Coherent Market Insights projects the global cannabis cultivation market to grow at a CAGR of 18.2% from 2020 to 2027. With the cannabis sector offering high growth prospects, let’s look at Canopy Growth’s initiatives.

Canopy Growth’s growth prospects

Canopy Growth’s management has estimated that the United States, Canada, and Germany account for 90% of the cannabis global addressable market. The company is thus focusing mainly on these three markets. In the Canadian recreational market, the company had expanded its market share by 200 basis points in its recently announced quarter to 15.5%.

The improvement in the quality of its value products, expansion of its Cannabis 2.0 portfolio, and its strong retail presence have helped the company expand its market share.

Canopy Growth has acquired a significant market share in the cannabis-infused beverage segment. Currently, it has introduced seven ready-to-drink THC beverages and two ready-to-drink CBD beverages in the Canadian markets. Further, the company opened nine retail stores in the second quarter to increase the number of corporate-owned store count to 32.

Moving to the United States, Canopy Growth had partnered with Martha Stewart to launch a portfolio of health and wellness CBD products in September 2020, which have received a positive response from customers. Its subsidiary, Biosteel Sports Nutrition, has signed distribution agreements with Manhattan Beer and Reyes Beer Division to expand the availability of its ready-to-drink sports beverages across the country.

Canopy Growth’s Storz & Bickel vaporizer products are witnessing strong growth amid distribution gains and reorders. The company has planned to triple its production this year to meet the increasing demand. Further, Canopy Growth intends to introduce THC-infused beverages in California and Illinois in association with Acreage Holdings. With its liquidity standing at $1.72 billion, the company is well-positioned to implement its growth initiatives.

Bottom line

Canopy Growth is yet to become profitable. However, the company’s management has taken several cost-cutting initiatives, such as the closure of production facilities and slashing of its workforce, to move towards profitability. The management expects to report positive EBITDA in fiscal 2022. Given its growing addressable market, expanding market share, and improving margin, I am bullish on Canopy Growth.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »